Carlsbad, Calif.-based Aurora said the implants are coated with a titanium plasma spraydesigned to encourage bpone ingrowth. The nod from the federal watchdog agency includes anterior cervical and transforaminal lumbar indications, according to a press release.
“This FDA clearance is a major achievement for Aurora Spine. These intervertebral implants are developed to support the entire spine from cervical to lumbar and to accommodate the company’s Zip minimally invasive interspinous fusion system portfolio as well as other fusion products on the market,” president & CEO Trent Northcutt said in prepared remarks.
Aurora is planning to use the proceeds from a $5 million stock offering toward the manufacturing, sales and marketing of its Zip spinal fusion line and other FDA-approved devices.
A 5.2-million-share- initial public offering in August 2013, priced at 70¢ per share, brought in $3.6 million for the spinal implant maker.